Skip to content
Fundology

ETF · VanEck

CYBG VanEck Medical Robotics and Bionic Engineering UCITS ETF Accum A USD

ISIN IE0005TF96I9Van Eck Associates Corp.

Reference data only

We hold this instrument’s identity from the FCA FIRDS register (ISIN, name, type, currency). Prices, charges and returns are not available for it yet.

Past returns

Total return: the change in the fund’s value with any income reinvested, after its ongoing charges.
1 year
−4.1%
−7.1% after inflation
3 years
−13.5%
−21.9% after inflation

Volatility and the largest fall need a longer record of this fund’s prices than we hold so far. They appear on this page once we do.

Returns: TradingView (delayed data). Inflation: ONS CPIH, latest month published.

How we work it out:ReturnsReturns after inflationTotal returnReal returnCPIH

In plain English

VanEck UCITS ETFs PLC - VanEck Medical Robotics and Bionic Engineering UCITS ETF Accum A USD is an exchange-traded fund (ETF) from VanEck, launched in 2022.

It tracks the MVIS Global Bionic Healthcare ESG Index - Benchmark TR Net.

You buy and sell it through a share-dealing account or platform during stock-market hours, like a share.

Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.

Technology: Software, chips, AI and other tech companies. One sector only, so prices can move more than a broad fund.

Terms:ETFIndex fundUCITSAccumulating or incomeShare classISIN

Key facts

Ticker
CYBG
ISIN
IE0005TF96I9
Provider
VanEck
Tracks
MVIS Global Bionic Healthcare ESG Index
Structure
ETF
An exchange-traded fund: bought and sold on the stock exchange through the day, like a share.
Income
Accumulating
Income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.
Fund size
£7.6m
Launched
Domicile
Ireland
Can be held in
ISA and SIPP
Currency hedged
No
Category
Technology

What it holds

The ten largest holdings make up 68.1% of the fund, as of .

Top 10 holdings

Top holdings of CYBG: the ten largest, as a percentage of the whole fund, as of 30/09/2026
Rank#HoldingWeight as a percentage of the fund
1Intuitive SurgicalISRG11.50%
2Edwards LifesciencesEW10.01%
3StrykerSYK9.99%
4MedtronicMDT9.38%
5DexComDXCM7.46%
6SonovaPHBN4.75%
7StraumannSTMN4.38%
8Zimmer BiometZBH3.97%
9Smith & NephewSN.3.52%
10Globus MedicalGMED3.15%

Source: VanEck, holdings as published, as of , company pages by TradingView

Where it invests

The portfolio by sector, country and type of asset, as a share of the whole fund. Bonds, cash and positions the source does not classify are shown as they come, not guessed.

By country

  1. United States80.0%
  2. Switzerland9.1%
  3. United Kingdom3.5%
  4. Australia2.8%
  5. Italy2.3%
  6. Denmark1.8%
  7. China0.4%
  8. Not classified0.1%
Added up from the holdings VanEck publishes, as of 30/09/2026.

By type of asset

  1. Equity99.9%
  2. Cash and money market0.1%
Added up from the holdings VanEck publishes, as of 30/09/2026.

26 holdings are listed for this fund. All 26 holdings of CYBG, with the full split by sector, country and type of asset.

More of the portfolio

The fund publishes 26 holdings; the ten largest make up 68.1% of it. The fund's portfolio is also split by currency.

Create a free account to see the full holdings list and the currency, maturity and credit-quality breakdowns

Sign-up takes an email address. There is no card to enter and nothing to pay.

Create a free accountSign in

Holdings:Compare what it holds with another fundHoldings overlapHow overlap is measured

Risk and return in depth

Ratios that weigh return against its ups and downs, every rolling period rather than a few fixed ones, and each large fall with how long it took to recover.

  • Rank among similar funds

    Rank by total return over 1 and 3 years among up to 66 technology funds investing globally, not currency-hedged, highest first.

    Pro

Pro — currently by invitation

Pro includes the rank among similar funds

Pro is open by invitation while it is being built. There is nothing to buy. To ask about access, email [email protected].

Questions people ask

What does CYBG track?

CYBG tracks the MVIS Global Bionic Healthcare ESG Index - Benchmark TR Net.

Is CYBG accumulating or distributing?

CYBG is accumulating: income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.

What is the ISIN of CYBG?

The ISIN of CYBG is IE0005TF96I9. An ISIN identifies one exact share class of a fund; CYBG is its ticker on the London Stock Exchange.

Similar funds

More technology funds, largest first. Size is a fact, not a verdict.
All technology fundsEvery fund we cover

Sources and dates

Returns
TradingView reported returns (net asset value with income reinvested where available)
Inflation
ONS CPIH, latest month published
Holdings
VanEck, as published,
Identity
FCA Financial Instruments Reference Data System (FIRDS) and the issuer
Fund size
TradingView, converted to pounds at the latest ECB reference rate

Methodology:Data sourcesReturnsCategoriesAll methods

A machine-readable copy of this page: Markdown.